Skip to content
ArrePath logo — Deciphering biology, discovering new classes of anti-infecti...

ArrePath

Deciphering biology, discovering new classes of anti-infectives.

Founded 2022 United States Princeton, United States 16 employees Seed Total: $20.00M Biotechnology, Health Care

General Information

Company Name ArrePath
Founded Year 2022
Location United States Princeton, United States
Employees 16
Industries Biotechnology, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with ArrePath. To contact ArrePath, visit arrepath.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ArrePath compare?

A PDF of ArrePath and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ArrePath soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ArrePath

ArrePath is a biotech company founded in 2022, with a slogan of "Deciphering biology, discovering new classes of anti-infectives." The company focuses on addressing antimicrobial resistance (AMR) by discovering and developing new classes of anti-infectives through advanced technologies and novel strategies. ArrePath applies world-class science, innovation in imaging, and AI / ML technologies to identify and develop novel drugs, aiming to tackle global health issues. The company's advanced machine learning (ML) and imaging-based drug discovery platform allows for the rapid and efficient identification of new drug classes, with a deep understanding of their mechanisms of action. ArrePath recently secured a $20.00M Seed Round investment on 03 March 2022, with participation from a consortium of investors including Insight Partners, Viva BioInnovator, BIVF, Innospark Ventures, PTX Capital, Nor'easter Ventures, and AriMed Advisors. As the company continues to pioneer in the biotechnology and healthcare sectors, their innovative approach and strong investor support position them for potential future growth and success.

Business keywords: biotech company, anti-infectives, antimicrobial resistance, drug discovery, AMR solutions, state of the art technologies, innovation in imaging, AI / ML technologies, novel drugs, global health issues, imaging-based drug discovery, mechanism of action, drug resistant infections, advanced technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $20.00M 7
Insight Partners, Viva BioInnovator +5
03 Mar 2022

ArrePath Alternatives & Competitors

View All Alternatives
ArrePath vs

Delivering Novel Anti-Infectives

Venture round
6 employees
Biotechnology, Health Care
ArrePath vs

Pioneering RNA-based therapeutic solutions for genetic disorders, anti-infectives, and oncology by l...

Grant
Biotechnology, Health Care
ArrePath vs

Precision Science Inspired by Human Biology

Acquired
271 employees
Biotechnology, Health Care

FAQ About ArrePath

Deciphering biology, discovering new classes of anti-infectives.
ArrePath was founded in 2022.
ArrePath is headquartered in Princeton, United States.
ArrePath operates in Biotechnology and Health Care. Its work centres on biotech company, anti-infectives, antimicrobial resistance and drug discovery.
ArrePath has approximately 16 employees.
ArrePath has completed 1 funding round, raising a total of $20.00M. The latest funding stage is Seed.
Top alternatives and competitors to ArrePath include MGB Biopharma Limited, Prosensa, Vividion Therapeutics, Inc., Hexagon Bio, Oblique Therapeutics AB (publ.). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ArrePath and MGB Biopharma Limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ArrePath, https://bouncewatch.com/company/arrepath, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout